AMICUS THERAPEUTICS, INC. Interest Expense, Debt, Excluding Amortization
AMICUS THERAPEUTICS, INC. reported Interest Expense, Debt, Excluding Amortization of $43.56 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebtExcludingAmortization · last filed 2026-02-20
- AMICUS THERAPEUTICS, INC. interest expense, debt, excluding amortization for the quarter ending 2025-12-31 was $10.74M, a 5.36% decline year-over-year.
- AMICUS THERAPEUTICS, INC. interest expense, debt, excluding amortization for the quarter ending 2025-09-30 was $11.04M, a 8.77% decline year-over-year.
- AMICUS THERAPEUTICS, INC. interest expense, debt, excluding amortization for the quarter ending 2025-06-30 was $10.93M, a 8.46% decline year-over-year.
- AMICUS THERAPEUTICS, INC. interest expense, debt, excluding amortization for the quarter ending 2025-03-31 was $10.84M, a 9.47% decline year-over-year.
- AMICUS THERAPEUTICS, INC. interest expense, debt, excluding amortization for fiscal 2025 was $43.56M, a 8.05% decline from fiscal 2024.
- AMICUS THERAPEUTICS, INC. interest expense, debt, excluding amortization for fiscal 2024 was $47.37M, a 0.53% decline from fiscal 2023.
- AMICUS THERAPEUTICS, INC. interest expense, debt, excluding amortization for fiscal 2023 was $47.63M, a 38.26% increase from fiscal 2022.
- AMICUS THERAPEUTICS, INC. interest expense, debt, excluding amortization for fiscal 2022 was $34.45M, a 13.04% increase from fiscal 2021.
| Period end | Interest Expense, Debt, Excluding Amortization 3 month | Interest Expense, Debt, Excluding Amortization 6 month | Interest Expense, Debt, Excluding Amortization 9 month | Interest Expense, Debt, Excluding Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $10.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $21.79M derived: sum of 2 quarters · filed 2026-02-20 | $32.72M derived: sum of 3 quarters · filed 2026-02-20 | $43.56M 10-K · filed 2026-02-20 |
| 2025-09-30 | $11.04M 10-Q · filed 2025-11-04 | $21.98M derived: sum of 2 quarters · filed 2025-11-04 | $32.81M 10-Q · filed 2025-11-04 | $44.17M derived: sum of 4 quarters · filed 2026-02-20 |
| 2025-06-30 | $10.93M 10-Q · filed 2025-07-31 | $21.77M 10-Q · filed 2025-07-31 | $33.12M derived: sum of 3 quarters · filed 2026-02-20 | $45.23M derived: sum of 4 quarters · filed 2026-02-20 |
| 2025-03-31 | $10.84M 10-Q · filed 2025-05-01 | $22.19M derived: sum of 2 quarters · filed 2026-02-20 | $34.30M derived: sum of 3 quarters · filed 2026-02-20 | $46.24M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-12-31 | $11.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $23.46M derived: sum of 2 quarters · filed 2026-02-20 | $35.40M derived: sum of 3 quarters · filed 2026-02-20 | $47.37M 10-K · filed 2026-02-20 |
| 2024-09-30 | $12.11M 10-Q · filed 2025-11-04 | $24.05M derived: sum of 2 quarters · filed 2025-11-04 | $36.02M 10-Q · filed 2025-11-04 | $48.36M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $11.94M 10-Q · filed 2025-07-31 | $23.91M 10-Q · filed 2025-07-31 | $36.25M derived: sum of 3 quarters · filed 2025-07-31 | $48.52M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $11.97M 10-Q · filed 2025-05-01 | $24.31M derived: sum of 2 quarters · filed 2025-05-01 | $36.58M derived: sum of 3 quarters · filed 2025-05-01 | $48.37M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $12.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $24.61M derived: sum of 2 quarters · filed 2025-02-19 | $36.40M derived: sum of 3 quarters · filed 2025-02-19 | $47.63M 10-K · filed 2025-02-19 |
| 2023-09-30 | $12.27M 10-Q · filed 2024-11-06 | $24.06M derived: sum of 2 quarters · filed 2024-11-06 | $35.29M 10-Q · filed 2024-11-06 | $45.70M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $11.79M 10-Q · filed 2024-08-08 | $23.02M 10-Q · filed 2024-08-08 | $33.43M derived: sum of 3 quarters · filed 2024-08-08 | $42.38M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $11.23M 10-Q · filed 2024-05-09 | $21.64M derived: sum of 2 quarters · filed 2024-05-09 | $30.59M derived: sum of 3 quarters · filed 2024-05-09 | $38.18M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $10.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $19.36M derived: sum of 2 quarters · filed 2024-02-28 | $26.95M derived: sum of 3 quarters · filed 2024-02-28 | $34.45M 10-K · filed 2024-02-28 |
| 2022-09-30 | $8.95M 10-Q · filed 2023-11-08 | $16.53M derived: sum of 2 quarters · filed 2023-11-08 | $24.03M 10-Q · filed 2023-11-08 | $31.70M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $7.59M 10-Q · filed 2023-08-08 | $15.09M 10-Q · filed 2023-08-08 | $22.76M derived: sum of 3 quarters · filed 2023-08-08 | $30.44M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $7.50M 10-Q · filed 2023-05-10 | $15.17M derived: sum of 2 quarters · filed 2023-05-10 | $22.85M derived: sum of 3 quarters · filed 2023-05-10 | $30.45M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $7.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $15.35M derived: sum of 2 quarters · filed 2023-03-01 | $22.95M derived: sum of 3 quarters · filed 2023-03-01 | $30.47M 10-K · filed 2023-03-01 |
| 2021-09-30 | $7.68M 10-Q · filed 2022-11-07 | $15.29M derived: sum of 2 quarters · filed 2022-11-07 | $22.81M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $7.60M 10-Q · filed 2022-08-04 | $15.13M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $7.52M 10-Q · filed 2022-05-10 | |||
| 2020-09-30 | $6.25M 10-Q · filed 2021-11-09 | $9.66M derived: sum of 2 quarters · filed 2021-11-09 | $13.24M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $3.41M 10-Q · filed 2021-08-05 | $7.00M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $3.58M 10-Q · filed 2021-05-10 | |||
| 2019-09-30 | $3.82M 10-Q · filed 2020-11-05 | $7.97M derived: sum of 2 quarters · filed 2020-11-05 | $12.78M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $4.15M 10-Q · filed 2020-08-10 | $8.96M 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $4.81M 10-Q · filed 2020-05-07 | |||
| 2016-12-31 | $208.00K 10-K/A · filed 2017-03-03 |